STAAR Surgical Company (STAA) News

STAAR Surgical Company (STAA): $115.95

0.97 (+0.84%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter STAA News Items

STAA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

STAA News Highlights

  • For STAA, its 30 day story count is now at 3.
  • Over the past 20 days, the trend for STAA's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • MOH are the most mentioned tickers in articles about STAA.

Latest STAA News From Around the Web

Below are the latest news stories about Staar Surgical Co that investors may wish to consider to help them evaluate STAA as an investment opportunity.

3 Outside-the-Box Healthcare Stocks That Could Set You Up for Life

On that note, the best healthcare stocks for long-term investing have one thing in common, no matter how obscure they might be to the public: Their business models never go out of style, and they probably never will. Molina Healthcare (NYSE: MOH) is an insurance provider that specializes in the low-income segment of the market. Molina's largest customer segment is Medicaid, which accounts for 78% of its revenue.

Yahoo | April 4, 2021

Got $2,800? Invest in Your Family's Future With These 2 Stocks

If you're considering investing your family's stimulus funds in the stock market, it's paramount to be responsible. It's key to look for stocks that have an evergreen business model and a long history of successful execution, rather than tempting targets like hot-shot penny stocks or speculation plays. As its name somewhat implies, STAAR Surgical (NASDAQ: STAA) makes surgically implantable lenses for ophthalmology that correct a variety of ocular issues ranging from nearsightedness to astigmatism.

Yahoo | March 28, 2021

STAAR Surgical Company's (NASDAQ:STAA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

STAAR Surgical (NASDAQ:STAA) has had a rough month with its share price down 27%. However, stock prices are usually...

Yahoo | March 15, 2021

STAAR Surgical Reports Fourth Quarter and Full Year 2020 Results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and fiscal year ended January 1, 2021. Fourth Quarter 2020 Overview Net Sales of $46.0 Million Up 18% from the Prior Year Quarter ICL Sales of $39.8 Million Up 20% from the Prior Year Quarter ICL Units Up 13% from the Prior Year Quarter Gross Margin at

Business Wire | February 24, 2021

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 24, 2021

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended January 1, 2021 on Wednesday, February 24, 2021 after the market close. STAAR will host a conference call and webcast on Wednesday, February 24 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial

Business Wire | February 10, 2021

Broadwood Partners, L.P. Sells 48,687 Shares of STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. sold 48,687 shares of STAAR Surgical stock in a transaction on Thursday, February 4th. The shares were sold at an average price of $111.15, for a total value of $5,411,560.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available […]

Watchlist News | February 6, 2021

Elizabeth Yeu, M.D. and K. Peony Yu, M.D. Appointed to STAAR Surgical Board of Directors

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the appointments of Elizabeth Yeu, M.D., Partner, Virginia Eye Consultants, and K. Peony Yu, M.D., retired Chief Medical Officer, FibroGen Inc., to its Board of Directors, effective January 21, 2021. “The addition of Dr. Elizabeth Yeu and Dr. K. Peony Yu to our Board of Directors illustrates

Business Wire | January 26, 2021

Is It Too Late To Consider Buying STAAR Surgical Company (NASDAQ:STAA)?

While STAAR Surgical Company ( NASDAQ:STAA ) might not be the most widely known stock at the moment, it led the...

Yahoo | January 12, 2021

Canaccord Genuity Stick to Their Buy Rating for Staar Surgical Company By Investing.com

Canaccord Genuity Stick to Their Buy Rating for Staar Surgical Company

Investing.com | January 11, 2021

STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2020 Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the fourth quarter and fiscal year ended January 1, 2021. The Company expects total net sales for the fourth quarter to be approximately $46 million and full year sales to be approximately $163 million. GAAP earnings per share is expected to be approximately $0.06 for the fourth quarter and approximately $0.12 for the fiscal year ended January 1, 2021. The Company expects cash and cash equivalents to be approximately $152 million at January 1, 2021.

Yahoo | January 10, 2021



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6493 seconds.